These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 11775264)

  • 1. Immune response to plasmid DNA encoding HPV16-L1 protein.
    Sun X; Si L; Cao Z; Wang Y; Liu T; Guo J
    Chin Med J (Engl); 2000 Mar; 113(3):277-80. PubMed ID: 11775264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmid encoding papillomavirus Type 16 (HPV16) DNA constructed with codon optimization improved the immunogenicity against HPV infection.
    Cheung YK; Cheng SC; Sin FW; Xie Y
    Vaccine; 2004 Dec; 23(5):629-38. PubMed ID: 15542183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction and immunogenicity of human papillomavirus type 6b L1 recombinant plasmid.
    Liu F; Wang JB; Zuo YG; Liu YH; Ma DL
    Chin Med Sci J; 2004 Sep; 19(3):233-6. PubMed ID: 15506656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A DNA vaccine constructed with human papillomavirus type 16 (HPV16) E7 and E6 genes induced specific immune responses.
    Yan Q; Cheung YK; Cheng SC; Wang XH; Shi M; Hu MH; Yong X
    Gynecol Oncol; 2007 Jan; 104(1):199-206. PubMed ID: 17049969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of mucosal and systemic immune responses following oral immunization of mice with Lactococcus lactis expressing human papillomavirus type 16 L1.
    Cho HJ; Shin HJ; Han IK; Jung WW; Kim YB; Sul D; Oh YK
    Vaccine; 2007 Nov; 25(47):8049-57. PubMed ID: 17936447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parenteral and oral immunization with a plasmid DNA expressing the human papillomavirus 16-L1 gene induces systemic and mucosal antibodies and cytotoxic T lymphocyte responses.
    Rocha-Zavaleta L; Alejandre JE; Garcia-Carranca A
    J Med Virol; 2002 Jan; 66(1):86-95. PubMed ID: 11748663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved efficiency of a Salmonella-based vaccine against human papillomavirus type 16 virus-like particles achieved by using a codon-optimized version of L1.
    Baud D; Ponci F; Bobst M; De Grandi P; Nardelli-Haefliger D
    J Virol; 2004 Dec; 78(23):12901-9. PubMed ID: 15542642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced immunogenicity of human papillomavirus 16 L1 genetic vaccines fused to an ER-targeting secretory signal peptide and RANTES.
    Kim SJ; Lee C; Lee SY; Kim I; Park JS; Sasagawa T; Ko JJ; Park SE; Oh YK
    Gene Ther; 2003 Aug; 10(15):1268-73. PubMed ID: 12858192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of HPV6b L1/EBV LMP2 multiepitope and immunogenicity in mice.
    Zhu S; Xue X; Liu J; Lu L; Zhao P; Wang J; Li W; Zhang L
    Acta Biochim Biophys Sin (Shanghai); 2010 Aug; 42(8):515-21. PubMed ID: 20705592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective immunity against Chlamydia trachomatis genital infection induced by a vaccine based on the major outer membrane multi-epitope human papillomavirus major capsid protein L1.
    Xu W; Liu J; Gong W; Chen J; Zhu S; Zhang L
    Vaccine; 2011 Mar; 29(15):2672-8. PubMed ID: 21324344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficiency of HPV 16 L1/E7 DNA immunization: influence of cellular localization and capsid assembly.
    Kuck D; Leder C; Kern A; Müller M; Piuko K; Gissmann L; Kleinschmidt JA
    Vaccine; 2006 Apr; 24(15):2952-65. PubMed ID: 16414157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced mucosal and systemic immune responses following intravaginal immunization with human papillomavirus 16 L1 virus-like particle vaccine in thermosensitive mucoadhesive delivery systems.
    Park JS; Oh YK; Kang MJ; Kim CK
    J Med Virol; 2003 Aug; 70(4):633-41. PubMed ID: 12794729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salmonella enterica serovar Typhi Ty21a expressing human papillomavirus type 16 L1 as a potential live vaccine against cervical cancer and typhoid fever.
    Fraillery D; Baud D; Pang SY; Schiller J; Bobst M; Zosso N; Ponci F; Nardelli-Haefliger D
    Clin Vaccine Immunol; 2007 Oct; 14(10):1285-95. PubMed ID: 17687110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunogenicity of mutant and wild HPV16 DNA vaccines].
    Zuo YG; Wang JB; Jin HZ; Yue-hua L
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Oct; 26(5):554-7. PubMed ID: 15562771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immune response induced by vaccination with pseudotyped rAAV1 expressing HPV16 L1 protein].
    Zhou YB; Li ZL; Zhou L; Sheng W; Ma HT; Zeng Y
    Bing Du Xue Bao; 2008 Jul; 24(4):300-4. PubMed ID: 18780634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of human papillomavirus type 16 L1 protein in transgenic tobacco plants.
    Liu HL; Li WS; Lei T; Zheng J; Zhang Z; Yan XF; Wang ZZ; Wang YL; Si LS
    Acta Biochim Biophys Sin (Shanghai); 2005 Mar; 37(3):153-8. PubMed ID: 15756416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification and immunogenicity study of human papillomavirus type 16 L1 protein in Saccharomyces cerevisiae.
    Kim SN; Jeong HS; Park SN; Kim HJ
    J Virol Methods; 2007 Jan; 139(1):24-30. PubMed ID: 17034867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Preliminary study of HPV16 L1/E6-E7 chimeric recombinant DNA vaccine plasmid construction and expression in CHO cell].
    Zheng J; Zhang FP; Si LS; Dong XP; Wang YL
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Mar; 17(1):66-9. PubMed ID: 12870023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HPV16 L1 capsid protein expressed from viable adenovirus recombinants elicits neutralizing antibody in mice.
    Berg M; Gambhira R; Siracusa M; Hoiczyk E; Roden R; Ketner G
    Vaccine; 2007 Apr; 25(17):3501-10. PubMed ID: 16914239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Transformation activity and antigenicity of the human papillomavirus type 58 E6E7 fusion gene mutant].
    Wang H; Yu JY; Li L
    Zhonghua Zhong Liu Za Zhi; 2013 Jul; 35(7):491-6. PubMed ID: 24257298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.